In contrast, the programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis suppresses T-cell activity in peripheral tissues, including the tumour microenvironment, by inhibiting effector T-cell function upon ligand engagement [2]. Here, CD274 is linked to neoplasm.